Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2023 · 10-Q
Revenue$31.74M$31.74M+17.4% vs Q2 2022 Net Income$435.00K$435.00KN/M vs Q2 2022 EPS Diluted$0.02$0.02N/M vs Q2 2022 Gross Profit$15,832,000+6.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,452,000−54.7% Free Cash Flowderived$2,275,000−56.7% Margins · derivedGross margin49.9%−5.2 pt vs Q2 2022
Operating margin3.9%+3.2 pt vs Q2 2022
Net margin1.4%+2.0 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 9, 2023 · 40 d after period end